T: +91 124 4708 700 |  E: [email protected]    

         

Search

         

         

Search

         

         

Despite controversy over claimed coronavirus cure, CORONIL may be hard to fight at the Indian registry

July 3, 2020 by Deepak Gogia IP, Patent
Home | IP | Despite controversy over claimed coronavirus cure, CORONIL may be hard to fight at the Indian registry

The trademark registry could become the focus of attention as it considers applications for the claimed coronavirus cure’s name.

Read Full Article

ABOUT THE AUTHOR

Deepak Gogia

Deepak Gogia is a Partner with K&S Partners and has over 25 years of experience in patent litigation. 

Detailed Profile Detailed Profile
More from the Author More from the Author

DISCLAIMER

As per the rules of the Bar Council of India, we are not permitted to solicit work and advertise. By clicking on the “I AGREE” button below, you acknowledge the following:

  • There has been no advertisement, personal communication, solicitation, invitation or inducement of any sort whatsoever from us or any of our members to solicit any work through this website;
  • The user wishes to gain more information about us for his/her own information and use;
  • The information about us is provided to the user only on his/her specific request and any information obtained or materials downloaded from this website is completely at the user’s volition and any transmission, receipt or use of this site would not create any lawyer-client relationship.

The information provided under this website is solely available at your request for informational purposes only, should not be interpreted as soliciting or advertisement. We are not liable for any consequence of any action taken by the user relying on material / information provided under this website. In cases where the user has any legal issues, he/she in all cases must seek independent legal advice.